Project description
New treatments for metabolic liver disease
Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease affecting up to 6 % of the general population and up to 40 % of obese individuals, often leading to severe liver conditions. Currently, only a single approved treatment exists. The ERC-funded 3DMASH project will study organotypic cultures from MASH patients and matched controls to map tissue interactions and identify new pharmacological targets. By co-culturing metabolically relevant tissues in microphysiological systems and applying network biology methods, the project will uncover extrahepatic signalling pathways that influence MASH disease phenotypes. Additionally, it will screen chemogenomic libraries of G protein-coupled receptors, ion channels and nuclear receptors to identify targets that either activate ‘healthy’ signals or inhibit ‘disease’ cues.
Objective
Metabolic dysfunction-associated steatohepatitis (MASH) is a prevalent liver disease that affects up to 6% of the general population and 15-40% of obese persons. MASH is characterized by intracellular triglyceride accumulation (steatosis), chronic inflammation and hepatocyte injury. Importantly, MASH is prone to progress into liver fibrosis, cirrhosis and hepatocellular carcinoma and, even if diagnosed early, the disease is associated with reductions in life expectancy of 2-4.5 years. Despite tremendous efforts, there are currently no approved pharmacological treatments for MASH. MASH is closely linked to obesity, sarcopenia, dyslipidemia and insulin resistance and it has become clear that adipose tissue, pancreas and skeletal muscle produce important signals that orchestrate hepatic metabolism, inflammation and fibrosis. However, the underlying mechanisms in humans remain poorly understood.
In the 3DMASH project, we will utilize organotypic cultures isolated from patients with a clinical diagnosis of MASH and matched controls to comprehensively map tissue interactions and to identify novel targets for pharmacological interventions. By combining co-culture of metabolically relevant tissues from healthy and diseased individuals in microphysiological systems (MPS) with network biology approaches, we will identify novel extrahepatic signaling that positively or negatively influence MASH disease phenotypes.
Moreover, we will use the established platform to screen chemogenomic libraries of G protein coupled receptors, ion channels and nuclear receptors to identify new pharmacologically accessible targets that activate “healthy” signals or inhibit “disease” cues. This project thus provides a conceptually novel perspective that considers MASH as a complex pathology caused by dysregulated tissue interactions and targets these disease mechanisms, which are neglected by current drug development programs, to finally develop effective treatments.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine pathology
- medical and health sciences clinical medicine hepatology
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.1 - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-ERC - HORIZON ERC Grants
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2024-COG
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
171 77 STOCKHOLM
Sweden
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.